Has a mission to harmonise and coordinate expansion and best practices in the use of blister packaging and automated dose dispensing (ADD), standardising criteria at European level to benefit people’s well-being and health
Maximum drug adherence
Guarantee of safety and zero errors
Trust, care and security
Technology at the service of health and people
Sustainability of the health system
ADD and ADHERENCE TO TREATMENT
The WHO defines adherence to long-term therapy as “the extent to which a person’s behavior—taking medication, following a diet, and/or executing lifestyle changes—corresponds with agreed recommendations from a health care provider.” Often, the terms adherence and compliance are used interchangeably. However, their connotations are somewhat different: adherence presumes the patient’s agreement with the recommendations, whereas compliance implies patient passivity. Both terms are problematic in describing medication-taking behavior because they exaggerate the physician’s control over the process of taking medications. The complex issues surrounding the taking of medication for chronic disease cannot easily be distilled into one word. Recognition of this complexity will help avoid assigning blame exclusively to the patient and assist in identifying effective solutions.
European Guidelines
The European Directorate for the Quality of Medicines and HealthCare (EDQM) of the Council of Europe published Guidelines on “Best Practice for the Automated Dose Dispensing (ADD) Process and Care and Safety of Patients”, a document to which Spain and the other EU countries are signatories.
Safeguarding the interests of ADD providers in the sphere of human pharmaceuticals.
Promoting ADD as a central aspect of pharmaceutical care.
Enhancing the effectiveness of the “EDQM” European guidelines adopted by the European Directory for the Quality of Medicines and HealthCare regarding ADD activity.